Subtopic Deep Dive
Epidemiological Trends in Kawasaki Disease Incidence
Research Guide
What is Epidemiological Trends in Kawasaki Disease Incidence?
Epidemiological trends in Kawasaki disease incidence refer to observed patterns in disease occurrence, including seasonal variations, geographic differences, and temporal changes, particularly pre- and post-COVID-19, analyzed through national registries.
Studies document rising incidence rates in Japan and varying global patterns, with KD affecting children under 5 years primarily. COVID-19 lockdowns correlated with reduced cases in some regions, while multisystem inflammatory syndromes emerged post-infection. Over 20 key papers from 2004-2021, including Uehara & Belay (2012) with 541 citations, track these shifts using cohort and registry data.
Why It Matters
Tracking incidence trends informs etiology hypotheses, such as environmental triggers, aiding outbreak preparedness (Uehara & Belay, 2012). Post-COVID observations link SARS-CoV-2 to Kawasaki-like diseases, guiding surveillance for MIS-C variants (Verdoni et al., 2020; Whittaker et al., 2020). Public health benefits include targeted interventions in high-risk areas like Japan, where Nakamura et al. (2012) reported increasing cases from nationwide surveys.
Key Research Challenges
Distinguishing MIS-C from KD
Kawasaki-like symptoms in MIS-C post-COVID-19 complicate incidence tracking, as Verdoni et al. (2020) observed severe outbreaks in Italy. Whittaker et al. (2020) noted overlapping features like coronary involvement in 58 UK children. Registries struggle with diagnostic criteria differentiation.
Quantifying COVID impact
Lockdowns reduced KD cases, but causality remains unclear without pre/post controls (Toubiana et al., 2020). Temporal associations in Paris showed delayed surges post-SARS-CoV-2 waves. Long-term registries are needed for trend validation.
Global data standardization
Geographic variations hinder comparisons, as Uehara & Belay (2012) compared Asia, Europe, US rates. Japan's high incidence from Nakamura et al. (2012) surveys contrasts with sparse data elsewhere. Harmonized reporting protocols are lacking.
Essential Papers
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
Brian W. McCrindle, Anne H. Rowley, Jane W. Newburger et al. · 2017 · Circulation · 3.5K citations
Background: Kawasaki disease is an acute vasculitis of childhood that leads to coronary artery aneurysms in ≈25% of untreated cases. It has been reported worldwide and is the leading cause of acqui...
An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study
Lucio Verdoni, Angelo Mazza, Annalisa Gervasoni et al. · 2020 · The Lancet · 2.5K citations
Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2
Elizabeth Whittaker, Alasdair Bamford, Julia Kenny et al. · 2020 · JAMA · 2.0K citations
In this case series of hospitalized children who met criteria for PIMS-TS, there was a wide spectrum of presenting signs and symptoms and disease severity, ranging from fever and inflammation to my...
Multisystem Inflammatory Syndrome in Children in New York State
Elizabeth Dufort, Emilia H. Koumans, Eric J. Chow et al. · 2020 · New England Journal of Medicine · 1.4K citations
The emergence of multisystem inflammatory syndrome in children in New York State coincided with widespread SARS-CoV-2 transmission; this hyperinflammatory syndrome with dermatologic, mucocutaneous,...
Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study
Julie Toubiana, Clément Poirault, Alice Corsia et al. · 2020 · BMJ · 1.1K citations
Abstract Objectives To describe the characteristics of children and adolescents affected by an outbreak of Kawasaki-like multisystem inflammatory syndrome and to evaluate a potential temporal assoc...
Kawasaki syndrome
Jane C. Burns, Mary P. Glodé · 2004 · The Lancet · 871 citations
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19
Leora R. Feldstein, Mark W. Tenforde, Kevin G. Friedman et al. · 2021 · JAMA · 835 citations
This case series of patients with MIS-C and with COVID-19 identified patterns of clinical presentation and organ system involvement. These patterns may help differentiate between MIS-C and COVID-19.
Reading Guide
Foundational Papers
Start with Burns & Glodé (2004, 871 citations) for KD overview, then Uehara & Belay (2012, 541 citations) for global epidemiology baselines, and Nakamura et al. (2012, 376 citations) for Japan incidence data establishing rising trends.
Recent Advances
Study Verdoni et al. (2020, 2454 citations) for Italian COVID-KD outbreak, Whittaker et al. (2020, 2015 citations) for PIMS-TS characteristics, and Feldstein et al. (2021, 835 citations) for US MIS-C comparisons.
Core Methods
Core techniques include nationwide registries (Nakamura et al., 2012), observational cohorts (Verdoni et al., 2020), and incidence rate calculations via Poisson models from hospitalization data (Uehara & Belay, 2012).
How PapersFlow Helps You Research Epidemiological Trends in Kawasaki Disease Incidence
Discover & Search
Research Agent uses searchPapers and exaSearch to query 'Kawasaki disease incidence post-COVID registries,' surfacing Verdoni et al. (2020) with 2454 citations. citationGraph reveals connections from Uehara & Belay (2012) to recent MIS-C papers, while findSimilarPapers expands to Whittaker et al. (2020).
Analyze & Verify
Analysis Agent employs readPaperContent on Nakamura et al. (2012) to extract 2009-2010 Japan incidence rates, then runPythonAnalysis with pandas to plot temporal trends from multiple registries. verifyResponse via CoVe cross-checks claims against GRADE B evidence from McCrindle et al. (2017), ensuring statistical rigor in rate comparisons.
Synthesize & Write
Synthesis Agent detects gaps in post-2021 trends via contradiction flagging between pre-COVID rises (Uehara & Belay, 2012) and lockdown drops. Writing Agent uses latexEditText, latexSyncCitations for McCrindle (2017), and latexCompile to generate reports; exportMermaid diagrams seasonal patterns from Verdoni et al. (2020).
Use Cases
"Plot KD incidence rates from Japanese registries pre/post-2010 using Python."
Research Agent → searchPapers('Nakamura 2012 Kawasaki') → Analysis Agent → readPaperContent → runPythonAnalysis(pandas plot incidence vs year) → matplotlib graph of rising trends.
"Draft LaTeX review comparing KD and MIS-C incidence post-COVID."
Synthesis Agent → gap detection(Verdoni 2020, Whittaker 2020) → Writing Agent → latexEditText(structured sections) → latexSyncCitations(Uehara 2012) → latexCompile → PDF with incidence tables.
"Find code for analyzing KD geographic variation models."
Research Agent → paperExtractUrls(Uehara 2012) → paperFindGithubRepo → Code Discovery → githubRepoInspect → pandas scripts for mapping Asia-Europe-US rates.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ KD epidemiology papers, chaining searchPapers → citationGraph → GRADE grading for structured incidence report. DeepScan applies 7-step analysis to Verdoni et al. (2020), verifying COVID-KD links with CoVe checkpoints. Theorizer generates hypotheses on infectious triggers from Uehara & Belay (2012) trends.
Frequently Asked Questions
What defines epidemiological trends in KD incidence?
Patterns include seasonal peaks, rising rates in Japan (Nakamura et al., 2012), and post-COVID drops during lockdowns (Toubiana et al., 2020).
What methods track KD incidence?
Nationwide surveys like Japan's 2009-2010 registry (Nakamura et al., 2012) and cohort studies (Verdoni et al., 2020) use diagnostic criteria and hospitalization data.
What are key papers on KD trends?
Uehara & Belay (2012) compares global epidemiology (541 citations); McCrindle et al. (2017) provides AHA guidelines (3541 citations); Verdoni et al. (2020) links to COVID (2454 citations).
What open problems exist?
Unresolved etiologies despite trends; distinguishing MIS-C from KD (Whittaker et al., 2020); need for post-2021 global registries.
Research Kawasaki Disease and Coronary Complications with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Epidemiological Trends in Kawasaki Disease Incidence with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers